The FHIN — Intelligence for Institutions that Matter
The Federal Health Intelligence Network connects sovereign health institutions, federal research agencies, and academic centers with institutional-grade pharma intelligence. Built for the highest levels of governance and scientific rigor.
Apply for Network Access →What is FHIN?
The Network
FHIN is not a database or software platform. It is a sovereign institutional network — a membership body for federal health agencies, sovereign health institutions, academic medical centers, and government research organizations that require institutional-grade pharmaceutical intelligence.
Members access the AimwellBio platform, proprietary signal sources, and direct collaboration with other institutional members across regulatory, clinical, and scientific domains.
The Standard
FHIN establishes the institutional standard for pharma intelligence verification, compliance, and governance. All members operate under the same data validation protocols, audit trails, and security frameworks.
FHIN membership is invitation-based. Qualification requires federal charter, sovereign institutional status, or established academic research authority in healthcare policy or clinical science.
Who Qualifies?
HHS components, NIH institutes, FDA divisions, and statutory health authorities with direct regulatory or research mandates.
National health systems, government research organizations, and health authorities with international governance standing.
University-based research centers, academic medical centers, and public health institutions with NIH- or NSF-funded research programs.
Network Tiers
Three membership levels tailored to institutional scope and governance requirements.
Entry-level membership for institutions beginning institutional intelligence adoption.
- Access to AimwellBio platform
- Core signal streams
- Standard briefings
- Quarterly network calls
- Community forum access
Exclusive membership for institutions establishing FHIN governance precedent.
- All Contributor benefits
- Premium signal access
- Executive briefings
- Advisory board seat
- API access
- Direct engineering support
- Custom integrations
National health systems and sovereign health institutions with multi-agency scope.
- All Founding benefits
- Multi-agency licensing
- Bespoke intelligence
- Governance delegation
- White-label options
- 24/7 institutional support
Network Benefits
What FHIN membership delivers beyond individual platform access.
Direct collaboration with federal health agencies, sovereign health institutions, and leading academic centers. Closed network — FHIN members only.
Unified audit standards, SOC 2 Type II compliance, HIPAA data handling protocols, and regulatory documentation for institutional oversight.
Weekly synthesis intelligence prepared by institutional analysts, tailored to federal or sovereign agency governance cycles.
Founding and Sovereign tiers receive dedicated engineering support for custom integrations, data workflows, and API implementations.
Founding and Sovereign members vote on signal sources, briefing formats, and platform roadmap priorities.
Full historical access to five years of verified signals for trend analysis, competitive mapping, and policy development.
Verification & Qualification Process
How institutions join the network.
Institutional credentials, use case, and governance structure. Takes 10 minutes.
AimwellBio and network advisory board review institutional standing and charter. 2-3 weeks.
30-minute conversation with AimwellBio leadership on tier selection and integration. 1 week.
Platform access, SSO setup, data workflows, and first executive briefing. 2 weeks.
Resources for Practitioners
For individual healthcare professionals and researchers seeking institutional intelligence.
Individual access to pharmacovigilance briefings, clinical trial tracking, and regulatory signals — in your institutional capacity.
Explore Professional Access →Institutional documentation, API references, compliance guides, and best practices for FHIN integration.
View Knowledge Base →Public weekly briefings on major pharma and biotech signals. A sample of what FHIN delivers to member institutions.
Read Latest Briefings →Join the Network
FHIN membership is selective and invitation-based. Federal health agencies, sovereign institutions, and academic research centers with institutional governance standing can apply for membership evaluation.